Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 182 results found. Search for [ Adar Poonawalla SII ]

Results 1 to 21 of 182
PTI
June 5, 2021
While the firms will continue to make these three vaccines, this action will allow US-based companies that supply these vaccine manufacturers to make their own decisions on which orders to fulfil first


BusinessToday.In
New Delhi, June 3, 2021
Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday. Russia's RDIF sovereign wealth fund, which is marketing Sputnik V globally, has already signed agreements with six leading Indian manufacturers including Dr Reddy's Laboratories, Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech. The vaccine is currently being manufactured in India by Dr Reddy's Laboratories. The SII has also sought approval for test analysis and examination. Once permitted, the company will need to conduct clinical trials. Watch the video for more.Also Read: Serum Institute seeks nod for licence to manufacture Sputnik V in India


PTI
May 30, 2021
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.


PTI
May 23, 2021
In a letter to the Union Health Ministry, SII clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said


BusinessToday.In
May 18, 2021
As per block deal data available on BSE, Adar Poonawalla sold 31,57,034 shares at Rs 373.85 per share, taking the total deal value to Rs 118.02 crore


PTI
May 18, 2021
During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply


BusinessToday.In
May 14, 2021
Besides asking the Adar Poonawalla-backed pharma behemoth to come to its rescue, the Delhi government's letter mentioned that vaccination centres will have to be shut down due to the non-availability of vaccines


Manoj Sharma | Mudit Kapoor
May 13, 2021
At Rs 300, the expected earnings from, let's say, 500 million doses of Covishield stand at about Rs 15,000 crore, which is near three times the total revenue of Serum Institute in FY20


BusinessToday.In
May 13, 2021
Talking to the media following a state cabinet meeting, Maharashtra Health Minister Rajesh Tope said the vaccination for the 18-44 years age group will start after Covishield vaccine doses are received


PTI
May 12, 2021
The aid to India is part of the $1 million which the British-Swedish multinational has earmarked for relief initiatives across communities which have been hit hard by the coronavirus pandemic


PTI
May 6, 2021
Providing raw materials for the production of anti-coronavirus vaccines was a major component of the Biden administration's announcement on medical aid to India


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


BusinessToday.In
May 3, 2021
Poonawalla said SII has got 100 per cent advance of Rs 1,732.50 crore by GoI for the next tranche of 11 crore doses in the next few months.


BusinessToday.In
May 3, 2021
Coronavirus in India: \"Everybody really felt that India had started to turn the tide on the pandemic,\" said Poonawalla


BusinessToday.In
May 2, 2021
Earlier, Poonawalla had dropped a bombshell by saying in an interview he had extended his stay in London because of the threatening phone calls he had been receiving.


BusinessToday.In
May 1, 2021
Poonawalla said he had been getting phone calls from the \"most powerful\" in India, including chief ministers, business leaders and others for immediate supply of Covishield vaccine.


PTI
May 1, 2021
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country


BusinessToday.In
May 1, 2021
The pharma giant, which manufactures the AstraZeneca COVID-19 vaccine is going to make a formal announcement in the next few days


BusinessToday.In
April 28, 2021
Besides the central and state governments, Serum Institute of India (SII) and Bharat Biotech have also been made parties to the PIL


BusinessToday.In
April 26, 2021
India's long request has finally been addressed following a huge outrage over the US wavering on providing vital supplies to India when the country is facing an unprecedented spike in COVID-19 cases


PAGES 1 OF 10  12345